| Online-Ressource |
Verfasst von: | De-Colle, Chiara [VerfasserIn]  |
| Abdollahi, Amir [VerfasserIn]  |
| Debus, Jürgen [VerfasserIn]  |
| Baumann, Michael [VerfasserIn]  |
Titel: | SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy |
Verf.angabe: | Chiara De-Colle, Apostolos Menegakis, David Mönnich, Stefan Welz, Simon Boeke, Bence Sipos, Falko Fend, Paul-Stefan Mauz, Inge Tinhofer, Volker Budach, Jehad Abu Jawad, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Claus Belka, Ute Ganswindt, Steffi Pigorsch, Stephanie E. Combs, Fabian Lohaus, Annett Linge, Mechthild Krause, Michael Baumann, Daniel Zips |
Jahr: | 2018 |
Jahr des Originals: | 2017 |
Umfang: | 7 S. |
Teil: | volume:126 |
| year:2018 |
| number:1 |
| pages:125-131 |
| extent:7 |
Fussnoten: | Available online 20 October 2017 ; Gesehen am 10.10.2018 |
Titel Quelle: | Enthalten in: Radiotherapy and oncology |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1983 |
Jahr Quelle: | 2018 |
Band/Heft Quelle: | 126(2018), 1, Seite 125-131 |
ISSN Quelle: | 1879-0887 |
Abstract: | Introduction: Preclinical and clinical data suggest that the chemokine pathway governed by SDF-1 and CXCR4 contributes to a resistant phenotype. This retrospective biomarker study aims to explore the specific prognostic value of SDF-1 and CXCR4 expression in locally advanced head and neck squamous cell carcinomas (HNSCC) treated with primary radiochemotherapy (RT-CT). Material and methods: Biopsies from 141 HNSCC tumours of the oral cavity, oropharynx and hypopharynx were evaluated for SDF-1 and CXCR4 expression by immunofluorescence. SDF-1 and CXCR4 expression was correlated with clinico-pathological characteristics and outcome after RT-CT.Results: Patients with tumours exhibiting overexpression of intracellular SDF-1 and CXCR4 have a higher risk for loco-regional relapse and a worse overall survival after RT-CT (multivariate analysis, hazard ratio 2.33, CI [1.18-4.62], p = 0.02 and hazard ratio 2.02, CI [1.13-3.59], p = 0.02, respectively). Similar results were observed when only the subgroup of HPV DNA negative patients were analysed (hazard ratio 2.23 and 2.16, p = 0.02 and p = 0.01, respectively).Conclusions: Our data support the importance of SDF-1 and CXCR4 expression for loco-regional control and overall survival in HNSCC after primary radiochemotherapy. Prospective multivariate validation and further studies into CXCR4 inhibition to overcome radiation resistance are warranted. |
DOI: | doi:10.1016/j.radonc.2017.10.008 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: http://dx.doi.org/10.1016/j.radonc.2017.10.008 |
| Volltext: https://linkinghub.elsevier.com/retrieve/pii/S0167814017326488 |
| DOI: https://doi.org/10.1016/j.radonc.2017.10.008 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1581718586 |
Verknüpfungen: | → Zeitschrift |
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy / De-Colle, Chiara [VerfasserIn]; 2018 (Online-Ressource)